In8Bio (INAB) Current Assets (2020 - 2026)

In8Bio has disclosed Current Assets across 7 years of filings, most recently posting $18.5 million for Q2 2026.

• In Q2 2026, Current Assets rose 34.6% year-over-year to $18.5 million; the TTM figure through Jun 2026 stood at $18.5 million (up 34.6% YoY), while the FY2025 annual figure was $27.9 million, up 121.66% from the prior year.
• Current Assets came in at $18.5 million for Q2 2026 at In8Bio, down from $22.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $33.3 million in Q1 2022 to a low of $6.7 million in Q3 2024.
• Average Current Assets over 5 years is $19.2 million, with a median of $18.5 million recorded in 2026.
• Year-over-year, Current Assets jumped 121.9% in 2022 and sank 59.5% in 2024.
• Over 5 years, Current Assets stood at $22.2 million in 2022, then advanced by 10.75% to $24.6 million in 2023, then tumbled by 48.92% to $12.6 million in 2024, then jumped by 121.66% to $27.9 million in 2025, then tumbled by 33.66% to $18.5 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $18.5 million in Q2 2026, $22.7 million in Q1 2026, and $27.9 million in Q4 2025.